Literature DB >> 3344469

Combined thyrotroph and lactotroph cell hyperplasia simulating prolactin-secreting pituitary adenoma in long-standing primary hypothyroidism.

E P Pioro1, B W Scheithauer, E R Laws, R V Randall, K T Kovacs, E Horvath.   

Abstract

Primary hypothyroidism accompanies more than 50% of clinically significant pituitary thyrotroph adenomas. Hypothyroidism may also produce pituitary enlargement secondary to thyrotroph hyperplasia and present with a sellar mass and hyperprolactinemia. Three hypothyroid patients who presented with presumed prolactin-producing adenomas are reported. Although laboratory and radiologic abnormalities of pituitary enlargement may resolve after corrective thyroid therapy, our patients showed no such response and underwent operation. Histologic examination revealed no adenomas, but thyrotroph and lactotroph hyperplasia were present. Thyrotroph hyperplasia probably results from lack of negative feedback of thyroid hormone upon the anterior pituitary. Whether this is due to hypothalamic release of thyrotropin-releasing hormone (TRH) or another mechanism is unclear. Lactotroph hyperplasia may result from excess TRH, which stimulates lactotrophs with resultant hyperprolactinemia, or from reduced hypothalamic dopamine, thereby facilitating prolactin secretion. This study suggest that (a) hyperprolactinemia in hypothyroidism is not necessarily due to the "stalk section effect" secondary to pituitary enlargement, and (b) patients with primary hypothyroidism and sellar mass should initially be managed medically so that potentially reversible pituitary hyperplasia is not mistaken for adenoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3344469     DOI: 10.1016/0090-3019(88)90010-9

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  10 in total

1.  Tumefactive postmenopausal gonadotroph cell hyperplasia.

Authors:  Mark Jentoft; Bernd W Scheithauer; Olga Moshkin; Eva Horvath; Phillip C Collins; Luis V Syro; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

2.  MRI of pituitary hyperplasia in hypothyroidism.

Authors:  L J Wolansky; G D Leavitt; B J Elias; H J Lee; A Dasmahapatra; W Byrne
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

3.  The differential diagnosis of lesions involving the sella turcica.

Authors:  K Kovacs; E Horvath
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 4.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

Review 5.  Pituitary hyperplasia.

Authors:  E Horvath; K Kovacs; B W Scheithauer
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

6.  Cytology of pituitary thyrotroph hyperplasia in protracted primary hypothyroidism.

Authors:  A M Alkhani; M Cusimano; K Kovacs; J M Bilbao; E Horvath; W Singer
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

7.  Transdifferentiation of pituitary thyrotrophs to lactothyrotrophs in primary hypothyroidism: case report.

Authors:  Mark E Jentoft; Robert Y Osamura; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Virchows Arch       Date:  2012-07-03       Impact factor: 4.064

8.  Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemistry, electron microscopy, and in situ hybridization.

Authors:  V Jay; K Kovacs; E Horvath; R V Lloyd; H S Smyth
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Low Growth Hormone Levels in Short-Stature Children with Pituitary Hyperplasia Secondary to Primary Hypothyroidism.

Authors:  Minghua Liu; Yanyan Hu; Guimei Li; Wenwen Hu
Journal:  Int J Endocrinol       Date:  2015-09-02       Impact factor: 3.257

10.  [Intradialytic arterial hypotension in a patient on chronic hemodialysis revealing ante-hypophyseal insufficiency].

Authors:  Jaouad El Maghraoui; Hanane Ouahabi; Nadia Kabbali; Mohamed Arrayhani; Farida Ajdi; Tariq Sqalli Houssaini
Journal:  Pan Afr Med J       Date:  2016-05-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.